{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:55:25Z","timestamp":1787007325432,"version":"build-2736575974"},"reference-count":45,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100020955","name":"GlaxoSmithKline Biologicals SA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100020955","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Vaccines"],"published-print":{"date-parts":[[2024,12,31]]},"DOI":"10.1080\/14760584.2024.2323128","type":"journal-article","created":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T05:53:05Z","timestamp":1709272385000},"page":"303-311","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":12,"title":["The potential public health impact of the respiratory syncytial virus prefusion F protein vaccine in people aged \u226560 years in Japan: results of a Markov model analysis"],"prefix":"10.1080","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9492-8798","authenticated-orcid":false,"given":"Daisuke","family":"Kurai","sequence":"first","affiliation":[{"name":"Department of General Medicine, Kyorin University School of Medicine","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9507-199X","authenticated-orcid":false,"given":"Akiko","family":"Mizukami","sequence":"additional","affiliation":[{"name":"GSK","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-8299","authenticated-orcid":false,"given":"Victor","family":"Preckler","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8399-743X","authenticated-orcid":false,"given":"Frederik","family":"Verelst","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-3812","authenticated-orcid":false,"given":"Daniel","family":"Molnar","sequence":"additional","affiliation":[{"name":"GSK","place":["Wavre, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0591-4261","authenticated-orcid":false,"given":"Taizo","family":"Matsuki","sequence":"additional","affiliation":[{"name":"GSK","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1943-5533","authenticated-orcid":false,"given":"Yufan","family":"Ho","sequence":"additional","affiliation":[{"name":"GSK","place":["Singapore, Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6307-6916","authenticated-orcid":false,"given":"Ataru","family":"Igarashi","sequence":"additional","affiliation":[{"name":"Department of Public Health, Yokohama City University","place":["Kanagawa, Japan"]},{"name":"The University of Tokyo","place":["Tokyo, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,3]]},"reference":[{"key":"e_1_3_10_3_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00466"},{"key":"e_1_3_10_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiz059"},{"key":"e_1_3_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13031"},{"key":"e_1_3_10_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5021"},{"key":"e_1_3_10_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/20499361221091413"},{"key":"e_1_3_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12928"},{"key":"e_1_3_10_9_1","doi-asserted-by":"publisher","DOI":"10.2217\/fvl-2023-0069"},{"issue":"4","key":"e_1_3_10_10_1","first-page":"87","article-title":"A case of RSV-B outbreak in a nursing home during the new coronavirus epidemic","volume":"43","author":"National Institute of Infectious Diseases (NIID)","year":"2022","unstructured":"National Institute of Infectious Diseases (NIID). A case of RSV-B outbreak in a nursing home during the new coronavirus epidemic. IASR. 2022;43(4):87\u201388.","journal-title":"IASR"},{"key":"e_1_3_10_11_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9060624"},{"key":"e_1_3_10_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-023-00792-3"},{"key":"e_1_3_10_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac300"},{"key":"e_1_3_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofy316"},{"key":"e_1_3_10_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043951"},{"key":"e_1_3_10_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy991"},{"key":"e_1_3_10_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit471"},{"key":"e_1_3_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.11.106"},{"key":"e_1_3_10_19_1","volume-title":"WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines","author":"World Health Organization","year":"2017","unstructured":"World Health Organization. WHO preferred product characteristics for respiratory syncytial virus (RSV) vaccines. Organization WH, editor. Geneva: Department of Immunization, Vaccines and Biologicals; 2017."},{"key":"e_1_3_10_20_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac327"},{"key":"e_1_3_10_21_1","unstructured":"GSK. GSK shares positive data for Arexvy its respiratory syncytial virus (RSV) older adult vaccine indicating protection over two RSV seasons. 2023 [cited 2023 Jun]. Available from: https:\/\/www.gsk.com\/en-gb\/media\/press-releases\/gsk-shares-positive-data-for-arexvy-its-respiratory-syncytial-virus-older-adult-vaccine-indicating-protection-over-two-rsv-seasons\/"},{"key":"e_1_3_10_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2209604"},{"key":"e_1_3_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/irv.13100"},{"key":"e_1_3_10_24_1","unstructured":"Portal site of Official Statistics of Japan (e-STAT). Estimation of population 2022. [cited 2023 Jun]. Available from: https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&toukei=00200524&tstat=000000090001"},{"key":"e_1_3_10_25_1","volume-title":"Efficacy of one dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in adults IDWeeK","author":"Ison MG","year":"2023","unstructured":"Ison MG, Papi A, Langley JM, et al. editors. Efficacy of one dose of the respiratory syncytial virus (RSV) prefusion F protein vaccine (RSVPreF3 OA) in adults IDWeeK. Boston MA (US): Oxford University Press; 2023."},{"key":"e_1_3_10_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08603-x"},{"key":"e_1_3_10_27_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-08555-2"},{"key":"e_1_3_10_28_1","unstructured":"GSK Data on File. 2023N539973_00."},{"key":"e_1_3_10_29_1","unstructured":"National Institute of Infectious Diseases. Annual report (2020): sentinel-reporting diseases (monthly) - number of cases and number of cases per sentinel by year sex and month. 2020 [cited 2023 Jun]. Available from: https:\/\/www.niid.go.jp\/niid\/images\/idwr\/ydata\/2020\/Syuukei\/Syu_22_3.xlsx"},{"key":"e_1_3_10_30_1","volume-title":"The 71st Japanese Association for Infectious Diseases East Japan meeting\/The 69th Japanese Society of Chemotherapy East Japan branch meeting 2022","author":"Takahashi H","unstructured":"Takahashi H, Sato Y, Yajima T, editors. #193 diagnostic status and clinical picture of adult RSV infection cases after the COVID-19 pandemic. The 71st Japanese Association for Infectious Diseases East Japan meeting\/The 69th Japanese Society of Chemotherapy East Japan branch meeting 2022; Sapporo."},{"key":"e_1_3_10_31_1","doi-asserted-by":"publisher","DOI":"10.1017\/S0950268821000340"},{"key":"e_1_3_10_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2858-y"},{"key":"e_1_3_10_33_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0105-2022"},{"key":"e_1_3_10_34_1","volume-title":"A Global Conference on Novel RSV Preventative and Therapeutic Interventions - RSVVW\u201923 7th ReSViNET Conference","author":"Molnar D","year":"2023","unstructured":"Molnar D, La E, Verelst F, editors. 33 - modeling the clinical and economic burden of respiratory syncytial virus (RSV) among adults \u226560 years of age in the United States. A Global Conference on Novel RSV Preventative and Therapeutic Interventions - RSVVW\u201923 7th ReSViNET Conference; 2023; Lisbon, Portugal: ReSViNET - Respiratory Syncytial Virus Foundation."},{"key":"e_1_3_10_35_1","unstructured":"Portal site of Official Statistics of Japan (e-STAT). Abridged life tables 2021 2021 [cited 2023 Apr]. Available from: https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&query=%E7%B0%A1%E6%98%93%E7%94%9F%E5%91%BD%E8%A1%A8&layout=dataset"},{"key":"e_1_3_10_36_1","unstructured":"Ortega Sanchez I Advisory Committee on Immunization Practices (ACIP) held on June 21 2023. 2023 [cited 2023 Jun]. Available from: http:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2023-06-21-23\/05-RSV-Adults-Ortega-Sanchez-508.pdf"},{"key":"e_1_3_10_37_1","unstructured":"Ministry of Health Labour and Welfare (MHLW). The number (%) of those who got vaccinated in the national immunization program [cited 2023 Apr]. Available from: https:\/\/www.mhlw.go.jp\/topics\/bcg\/other\/5.html"},{"key":"e_1_3_10_38_1","unstructured":"Portal site of official statistics of Japan (e-STAT). Statistics Of Medical Activities In Public Health Insurance 2021. 2021 [cited 2023 Apr]. Available from: https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&layout=datalist&toukei=00450048&tstat=000001029602&cycle=7&tclass1=000001166295&tclass2=000001166326&tclass3=000001166327&tclass4val=0"},{"key":"e_1_3_10_39_1","unstructured":"Portal site of official statistics of Japan (e-STAT). Patient Survey 2020. 2020 [cited 2023 Apr]. Available from: https:\/\/www.e-stat.go.jp\/stat-search\/files?page=1&layout=datalist&toukei=00450022&tstat=000001031167&cycle=7&tclass1=000001166809&tclass2=000001166811&tclass3=000001166812&tclass4=000001166813&cycle_facet=tclass1%3Acycle&tclass5val=0&metadata=1&data=1"},{"key":"e_1_3_10_40_1","unstructured":"European Centre for Disease Prevention and Control (ECDC). Intensified circulation of respiratory syncitial virus (RSV) and associated hospital burden in the EU\/EEA Stockholm 2022. [cited 2023 Jun]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/intensified-circulation-respiratory-syncytial-virus-rsv-and-associated-hospital"},{"key":"e_1_3_10_41_1","unstructured":"National Institute of Infectious Diseases (NIID). Infectious disease - surveillance. 2023 [cited 2023 Jul]. Available from: https:\/\/www.niid.go.jp\/niid\/en\/iasr-e.html"},{"key":"e_1_3_10_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.27896"},{"key":"e_1_3_10_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad012"},{"key":"e_1_3_10_44_1","unstructured":"Interac. Japan\u2019s Healthcare System vs The US | Statistics & Cost Comparison. 2023. Available from: https:\/\/interacnetwork.com\/japans-healthcare-system-vs-the-us-statistics-cost-comparison\/#:~:text=Comparative%20statistics healthy%20lifestyles%2C%20and%20preventing%20disease"},{"key":"e_1_3_10_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2018.11.241"},{"key":"e_1_3_10_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.03.927"},{"key":"e_1_3_10_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.023"}],"container-title":["Expert Review of Vaccines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14760584.2024.2323128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:50:22Z","timestamp":1759830622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14760584.2024.2323128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12,31]]}},"alternative-id":["10.1080\/14760584.2024.2323128"],"URL":"https:\/\/doi.org\/10.1080\/14760584.2024.2323128","relation":{},"ISSN":["1476-0584","1744-8395"],"issn-type":[{"value":"1476-0584","type":"print"},{"value":"1744-8395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierv20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2023-10-21","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-02-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-01","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}